Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Comparison of laboratory-developed methods for aztreonam plus ceftazidime-avibactam antimicrobial susceptibility testing for metallo-beta-lactamase-producing Enterobacterales
Bhatnagar, Amelia , Harris, Harley , Jacobs, Emily, Bumpus-White, Porscha , Balbuena, Rocío , Stambaugh, Haley, Crayton, Karlos, Haynie, Jennifer, Ilutsik, Justina Quintero, Longo, Cynthia , Singh, Sweety , Murray, Meghan, Sabour, Sarah , Machado, María-José , Simner, Patricia J. , Bhatnagar, Amelia S , Singh, Sweety , Sabour, Sarah , Robinson, Matthew L , Simner, Patricia J , Harris, Harley T. , Jacobs, Emily, Haynie, Jenn , Ilutsik, Justina, Bergman, Yehudit

Mayo Clinic

Journal of Clinical Microbiology | May 22, 2026 | Volume: 64 | Issue: 6 | Pages: No page available

10.1128/jcm.01800-25 | PMID 42171586 Get It

ABSTRACT Metallo-beta-lactamase (MBL)-producing Enterobacterales are a global public health concern. Infections caused by these pathogens are often hard to treat, with few effective agents currently available. While aztreonam-avibactam only recently gained U.S. and European regulatory approval, laboratories have implemented laboratory-developed tests (LDTs) using existing aztreonam and ceftazidime-avibactam reagents. We sought to compare the performance of four phenotypic methods, up to three reagent manufacturers, and two media manufacturers. One hundred two MBL-producing Enterobacterales isolates were evaluated at two sites (Centers for Disease Control and Prevention [CDC] and Johns Hopkins University [JHU] School of Medicine). The performance of four methods was evaluated: broth disk elution (BDE), disk stacking (DS), gradient diffusion strip stacking (SS), and a strip-to-disk proximity (strip-disk) method, which were compared to reference broth microdilution (rBMD) tested in parallel. Respective category agreement for CDC and JHU was 92.2% and 96.1% for BDE, 51%–76.5% and 31%–49% for DS, 71.6%–86.3% and 83.3%–86.3% for SS, and 82.4%–87.3% and 80%–89.2% for the strip-disk method. The SS essential agreement ranged from 46.1% to 62.7% for JHU and 54.9% to 92.2% for CDC. Interlaboratory reproducibility was 93.1% for rBMD, 92.2% for BDE, 47.1%–53.1% for DS, 76.5%–80% for SS, and 87.3%–88.9% for strip-disk. BDE was the only method that exceeded acceptable performance of >90% accuracy and reproducibility. DS had the lowest and most variable performance between sites and among the different disk manufacturers used. LDTs for combination testing can be highly variable, and further work is needed to improve standardization and harmonization to achieve accurate and reliable results for clinical purposes. IMPORTANCE Carbapenem-resistant Enterobacterales are classified as an urgent public health threat in the Centers for Disease Control and Prevention’s 2019 Antibiotic Resistance Threats Report. Among the most concerning resistance mechanisms are carbapenemase enzymes encoded on mobile genetic elements, which can spread rapidly between bacteria. Of the various carbapenemases, metallo-beta-lactamases are particularly challenging, as they confer resistance to nearly all beta-lactams, and current treatment options remain limited. While aztreonam-avibactam has been U.S. Food and Drug Administration (FDA)-approved for treating certain infections with limited or no alternative treatment options, no FDA-cleared susceptibility test is yet available. In this context, laboratory-developed methods, such as combination testing of aztreonam and ceftazidime-avibactam, play a critical role in guiding therapy. Our study evaluates several of the more common laboratory-developed tests compared to reference broth microdilution and found that broth disk elution was the most accurate; in contrast, other methods had variable performance, some demonstrating limited reliability and being prone to overcalling resistance.
Hearing Through the Patient’s Ears: Hearing Simulation for Counseling and Education
Kingsbury, Hailey, Kingsbury, Sarah , Cevette, Michael J. , Stepánek, Jan , Habr, Edwar, Itawi, Hussein, Pradhan, Gaurav N. , Kingsbury, Hailey A , Kingsbury, Sarah E , Pradhan, Gaurav N , Stepánek, Jan

Mayo Clinic

Audiology Research | May 22, 2026 | Volume: 16 | Issue: 3 | Pages: 77

10.3390/audiolres16030077 | PMID 42201131 Get It

Background/Objectives: Hearing loss is frequently misunderstood by communication partners and healthcare providers of patients with hearing loss alike, leading to gaps in counseling, medical adherence, and empathy. Hearing loss simulation is a technique that can clarify patient experience by illustrating how hearing loss affects daily listening and speech discrimination. The current research explores the influences of a web-based hearing loss simulator on how hearing loss is understood by communication partners, audiologists, and medical providers/students. Methods: Using a convergent parallel mixed-methods design, 72 participants (communication partners, audiologists, and medical providers/residents) completed a guided trial with the hearing simulator, either one-on-one or in group settings, and subsequently completed a questionnaire regarding their experiences. The simulation trial included demonstrations of hearing loss and amplification across four listening environments: speech in quiet, in noise, at a distance, as well as listening to instrumental music. Results: Communication partners reported that they gained a better understanding of their partner’s hearing loss, with all expressing increased feelings of empathy towards their partner and individuals with hearing loss. When compared to audiologists, communication partners were significantly more surprised by the impact of hearing loss on speech understanding. Medical providers and students emphasized the value of the simulator as a counseling tool and highly recommended that other providers use the simulator with their patients. Conclusions: Simulating hearing loss can be beneficial for counseling purposes and medical training. These findings suggest that hearing loss simulation can enhance empathy and communication across clinical and educational contexts.
Role of the Emergency Medicine Pharmacist in the Management of Boarding Patients: An Opinion of the Emergency Medicine Practice and Research Network of the American College of Clinical Pharmacy Endorsed by the SAEM Academy of Emergency Medicine Pharmacists
Gilbert, Brian W. , Zimmerman, David E. , Robertson, Alyssa , Jones, Gavin D. , Gendron, Bryan J. , Corio, Jessica L. , Harlan, Sarah S. , Engstrom, Kellyn , Maisenbach, Alexa , Rambaran, Kerry Anne , Mercer, Kevin , Geier, Curtis , Truoccolo, Donna Shuler , Blue, Heather , Mercer, Kevin , Feldman, Ryan , Geier, Curtis , Truoccolo, Donna Shuler , Weant, Kyle A , Blue, Heather , Harlan, Sarah Schuman

Mayo Clinic

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY | May 21, 2026 | Volume: 9 | Issue: 6 | Pages: No page available

10.1002/jac5.70227 | PMID 42161376 Get It

ABSTRACT As emergency department (ED) crowding and patient boarding reach critical levels nationwide, the role of the emergency medicine pharmacist (EMP) must be both defined and safeguarded. While EMPs are increasingly valued for their contributions to acute care, their responsibilities often unintentionally expand during periods of operational strain, particularly when admitted patients remain in the ED for prolonged durations. EMPs should ideally be resourced to remain focused on time‐sensitive, high‐risk medication management where their expertise is most impactful and not be used as default providers for all pharmacotherapy needs during ED boarding. This perspective outlines our position on the ideal scope of EMP practice during times of congestion, advocating for clearly defined role boundaries, strategic collaboration with other pharmacy team members, and system‐level support to prevent dilution of emergency care. EMPs must be empowered to prioritize critical ED workflows, support resuscitations, and lead initiatives in education, protocol development, and patient safety, without being overextended by responsibilities that can be absorbed by other team members.
Reading between the lists: Trends and decisions in delisting for clinical improvement
Khan, Sarah, Aby, Elizabeth S.

Mayo Clinic

Liver Transplantation | May 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/lvt.0000000000000907 | PMID 42155105 Get It

Elevated AD biomarkers do not explain cognitive performance in a community‐recruited clinical trial cohort
Landau, Susan , Taggett, Jacinda , Ward, Tyler J. , Murphy, Alice, Lovato, Laura, Koeppe, Robert, Farias, Sarah Tomaszewski , Snyder, Heather M. , Harvey, Danielle , Weiner, Michael W. , Baker, Laura D. , Jagust, William J. , Initiative, U.S. POINTER Study Group and Alzheimer's Disease Neuroimaging, Harvey, Danielle J , Liu, Peiwei , Harrison, Theresa M. , Lockhart, Samuel N. , Papp, Kathryn V. , Espeland, Mark Andrew , Maillard, Pauline , DeCarli, Charles , Vemuri, Prashanthi , Initiative, U.S. POINTER Study Group and Alzheimer's Disease Neuroimaging

Mayo Clinic

Alzheimer's & Dementia | May 19, 2026 | Volume: 22 | Issue: 5 | Pages: No page available

10.1002/alz.71472 | PMID 42151735 Get It

Abstract INTRODUCTION To examine the generalizability of Alzheimer's disease (AD) biomarker models in real‐world older adults, we examined AD biomarker relationships with cognition in two multicenter cohorts that differ with respect to recruitment approach and health risk factors but were matched on a variety of characteristics. METHODS We compared harmonized health and demographic data, AD and cerebrovascular biomarkers, and cognitive performance in the community‐recruited U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) Imaging substudy and a matched sample from the Alzheimer's Disease Neuroimaging Initiative (ADNI) which recruited primarily from academic specialty clinics. RESULTS Elevated β‐amyloid (Aβ) and tau were associated with cognitive performance in ADNI but not U.S. POINTER. Findings were consistent across different cohort matching schemes, and were not explained by discrepancies in vascular risk. DISCUSSION The role of Aβ and tau in cognitive performance may be reduced in real world samples compared to academic specialty clinics.
Murine modeling of IDH-mutant 1p/19q-codeleted oligodendroglioma reveals genotype specific phenotypes
Kundu, Ipsita, Toro, Nicolas, Langhnoja, Jaldeep, Ayyagari, Rithvik V, Cronk, James C, Arounleut, Phonepasong, Esqueda, Luis Tron, Fuller, Christine , Viswanath, Pavithra, Heimberger, Amy B. , Horbinski, Craig M, Phoenix, Timothy N. , Phoenix, Timothy N , Toro, Nicolas, Mochizuki, Aaron Y. , Langhnoja, Jaldeep , Cronk, James, Reel, Sarah Martin , Esqueda, Luis Tron , Viswanath, Pavithra , Heimberger, Amy B. , Horbinski, Craig

Mayo Clinic

No container title available | May 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.05.14.725183 | PMID 42239081 Get It

Abstract Oligodendroglioma is a primary central nervous system tumor classified by the presence of isocitrate dehydrogenase (IDH) mutations and codeletion of 1p/19q. Here we describe the generation of an IDH-mutant 1p/19q-codeleted oligodendroglioma mouse model using in utero electroporation. We identified IDH1 R132H , PIK3CA E545K , Cic KO , Fubp1 KO and Cdkn2a KO as the optimal combination (termed Oligo Cdkn2a ) to drive fully penetrant tumors that histologically resemble human grade II/III IDH-mutant, 1p/19q-codeleted oligodendroglioma. Replacing Cdkn2a with Trp53 loss in this mouse model shifted tumor histology towards high grade astrocytoma. Oligo Cdkn2a tumors displayed metabolic and transcriptional changes associated with IDH and CIC mutations, and single cell sequencing identified a bias towards oligodendrocyte differentiation compared to an IDH wild-type glioblastoma mouse model. Oligo Cdkn2a tumors represent the first mouse model system to recapitulate the genetic, histological and transcriptional features of human IDH-mutant 1p/19q-codeleted oligodendrogliomas, offering a platform to further dissect tumor biology and test new therapeutic strategies.
Role for endothelin-1 in cardiometabolic dysfunction with intermittent hypoxia
Gonsalves, Anna M. , Baker, SarahE., Limberg, Jacqueline K. , Limberg, Jacqueline K , Baker, Sarah E. , Singh, Prachi

Mayo Clinic

Function | May 18, 2026 | Volume: 7 | Issue: 3 | Pages: No page available

10.1152/function.014.2026 | PMID 42148870 Get It

Endothelin-1 (ET-1) has been linked to increased hypoxic sensitivity of the chemoreceptors and the development of cardiometabolic disease. Repeated hypoxic exposures [i.e., intermittent hypoxia (IH)] elicit increases in ET-1, muscle sympathetic nerve activity (MSNA), and blood pressure (BP). In this brief review, we summarize data from our group(s) which examined the effect of acute IH on MSNA, BP, and indices of adipose tissue lipolysis [i.e., free fatty acids (FFAs)], as well as the role of ET-1 in these responses. Herein, we show that acute ET receptor inhibition (oral bosentan) attenuates the rise in BP during hypoxia and the fall in BP during hyperoxia in healthy young men. Although the effect of IH on MSNA and BP was not attenuated following ET-receptor inhibition, IH increased plasma ET-1, epinephrine, and FFA concentrations. Notably, inhibition of ET-1 receptors with oral bosentan attenuated the IH-mediated rise in epinephrine and FFA. With these findings, we demonstrate a role for ET-1 in the maintenance of resting BP in young men, possibly through a chemoreceptor-mediated mechanism. We further speculate that the effect of ET-1 receptor inhibition on circulating FFA is secondary to its ability to reduce sympathoadrenal tone during IH exposure. Results highlighted in this review may serve as the basis for future work exploring ET-1 as a therapeutic target for cardiometabolic dysfunction associated with IH.
Multilocus Sequence Typing Reveals New Insights into the Population Structure and Genetic Diversity of Lactococcus spp. from Brazilian Fish
Tavares, Guilherme Campos , Carneiro, Sarah Portes , Barbanti, Angelo Carlo Chaparro , Rosário, Angélica Emanuely Costa do , Matos, Helena Caldeira , Maia, Cynthia Rafaela Monteiro da Silva, Costa, Henrique Lopes , Nogueira, Luiz Fagner Ferreira , Rosa, Júlio César Câmara , Pereira, Felipe Luiz, Pilarski, Fabiana , Gallani, Sílvia Umeda , Leal, Carlos Augusto Gomes , Figueiredo, Henrique César Pereira , Pereira, Felipe Luiz , Nogueira, Luiz Fagner Ferreira , Rosa, Júlio César Câmara , Pereira, Felipe Luiz , Pilarski, Fabiana , Gallani, Silvia Umeda , Leal, Carlos Augusto Gomes , Figueiredo, Henrique César Pereira , Egger, Renata Catão , Soto, Esteban

Mayo Clinic

Microorganisms | May 18, 2026 | Volume: 14 | Issue: 5 | Pages: 1131

10.3390/microorganisms14051131 | PMID 42197516 Get It

Lactococcosis has emerged as an economically and ecologically significant disease in aquatic animals worldwide. This study employed multilocus sequence typing (MLST) to investigate the genetic diversity of Lactococcus spp. strains from Brazilian fish species and evaluate their phylogenetic relationships with global isolates to elucidate potential epidemiological connections involving multiple host species and distinct geographic regions. A total of 55 isolates from different laboratories had their DNA extracted, followed by the amplification and sequencing of the internal fragments of seven housekeeping genes (als, atpA, tuf, gapC, gyrB, rpoC and galP). Sequence types (STs) and clonal complexes (CCs) were defined. An unrooted neighbor-joining phylogenetic tree was generated using allele profiles from this study and those previously reported from other aquatic animal species. The isolates comprised 29 STs (11 previously reported, 18 novel ones), which were grouped into species-specific CCs: CC5 (L. formosensis); CC4, CC17, CC62 (L. garvieae); CC24, CC29, CC97 (L. petauri). Considerable genetic divergence was observed, with L. formosensis and L. garvieae forming heterogeneous populations, while L. petauri was more homogeneous. These findings describe the MLST structure of the sampled isolates and should be interpreted as hypothesis-generating rather than population-level estimates of genotype prevalence. Phylogenetics confirmed groupings within the CCs and revealed additional phylogenetic clustering patterns. In conclusion, the Brazilian Lactococcus spp. strains analyzed in this study constitute a genetically diverse population based on their STs. MLST and phylogenetic analysis demonstrated genetic relatedness between the L. garvieae and L. formosensis isolates from this study and those from other aquatic animal species. In contrast, all the STs identified for L. petauri in this study were unrelated to the MLST lineages responsible for outbreaks in Brazilian Nile tilapia (Oreochromis niloticus) and North American rainbow trout (Oncorhynchus mykiss). This suggests that piscine L. petauri populations in the Americas evolved from distinct ancestral origins.
Intraprocedural lactation support for neurointerventional surgery
Settecase, Shaadi , Levinson, Anya, Dodd, Sarah E. , Leacy, Reade Andrew De, Quigley, Sarah , Ko, Nerissa, Lamboy, Allison, Amans, Matthew R. , Leacy, Reade De , De Leacy, Reade , Amans, Matthew

Mayo Clinic

Journal of NeuroInterventional Surgery | May 14, 2026 | Volume: 18 | Issue: 6 | Pages: 1489-1491

10.1136/jnis-2026-025558 | PMID 42134843 Get It